Skip to main content
Clinical Trials/NCT06679569
NCT06679569RecruitingNot Applicable

Effect of Deep Neuromuscular Blockade on Postoperative Pain in Pediatric Patients Undergoing Laparoscopic Surgery: a Prospective Randomized Controlled Trial

Seoul National University Hospital1 site in 1 country106 target enrollmentStarted: November 6, 2024Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
106
Locations
1
Primary Endpoint
ANIm (Analgesia Nociception Index) Value

Study Overview

Brief Summary

This study aims to investigate the impact of varying degrees of neuromuscular blockade on postoperative pain in pediatric patients aged over 2 months to under 7 years undergoing laparoscopic surgery under general anesthesia.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
2 Months to 7 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pediatric patients aged over 2 months to under 7 years scheduled for laparoscopic surgery under general anesthesia.
  • American Society of Anesthesiologists (ASA) Physical Status Classification I, II, or III.

Exclusion Criteria

  • Patients undergoing emergency surgery.
  • Patients with chronic pain or currently taking analgesics for chronic pain.
  • Known hypersensitivity to general anesthetic agents or analgesics.
  • Patients with underlying cardiovascular disease.
  • Patients with neuromuscular disorders.
  • Any other condition that, in the investigator's judgment, would make the patient unsuitable for participation in the study.

Arms & Interventions

moderate neuromuscular blockade

Active Comparator

Intervention: rocuronium 0.2 mg/kg/hr continuous infusion (Drug)

deep neuromuscular blockade

Experimental

Intervention: rocuronium 0.6 mg/kg/hr continuous infusion (Drug)

Outcomes

Primary Outcomes

ANIm (Analgesia Nociception Index) Value

Time Frame: 30 minutes after arrival in the recovery room

Secondary Outcomes

  • FLACC Pain Scale(30 minutes after arrival in the recovery room)
  • Pediatric Anesthesia Emergence Delirium Scale(30 minutes after arrival in the recovery room)
  • Time to Extubation(From end of surgery to extubation (in minutes, assessed up to 1 hour))
  • Recovery Room Length of Stay(Duration of stay in the recovery room (in minutes, assessed up to 2 hours))
  • Remifentanil Consumption During Anesthesia(During surgery ( assessed up to 5 hours))
  • Change in Pain Score (FLACC Pain Scale)(Every 6 hours up to 24 hours post-surgery)
  • Maximum Pain Score (FLACC Pain Scale) within 24 Hours(Within 24 hours post-surgery)
  • Total Narcotic/Non-Narcotic Analgesic Consumption per Body Weight(Within 24 hours post-surgery)
  • Peak Intraabdominal Pressure During Surgery(During surgery (assessed up to 5 hours))
  • Peak Inspiratory Pressure During Surgery(During surgery (assessed up to 5 hours))
  • Leiden Surgical Rating Scale(During surgery (assessed up to 5 hours))
  • Events During Recovery (Agitation, Stridor, Desaturation < 95%, Nausea, Vomiting, Bradycardia, Oxygen Requirement)(During recovery room stay (assessed up to 2 hours))
  • Any complications Occurring Before Discharge(Up to discharge (assessed up to 1 month))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ji-Hyun Lee

Professor

Seoul National University Hospital

Study Sites (1)

Loading locations...

Similar Trials